A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation
Clinical trial NCT04682509 · COMPLETED
Trial details
- NCT number
- NCT04682509
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-20
- Primary completion
- 2023-05-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.